| P2093 | author name string | Anuradha K Gajjar | |
| | Jignasa K Savjani | |
| | Ketan T Savjani | |
| P2860 | cites work | Cyclodextrin Drug Carrier Systems | Q60305154 |
| | Design and Evaluation of Celecoxib Porous Particles using Melt Sonocrystallization | Q62608200 |
| | Performance comparison of a co-crystal of carbamazepine with marketed product | Q63614923 |
| | Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate | Q72243313 |
| | Micronization: a method of improving the bioavailability of poorly soluble drugs | Q74727268 |
| | DISSOLUTION BEHAVIOR OF CRYSTALLINE SOLVATED AND NONSOLVATED FORMS OF SOME PHARMACEUTICALS | Q76539784 |
| | Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations | Q80490079 |
| | The role of cocrystals in pharmaceutical science | Q37158713 |
| | Pharmaceutical Applications of Solid Dispersion Systems | Q40000294 |
| | Preparation and in vitro evaluation of solid dispersions of halofantrine | Q43906253 |
| | A novel particle engineering technology: spray-freezing into liquid. | Q44100923 |
| | Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids | Q44505048 |
| | Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin | Q44884207 |
| | Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology | Q45080942 |
| | Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids | Q45102725 |
| | Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective | Q45155831 |
| | Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound | Q46437949 |
| | The effect of polymorphism on powder compaction and dissolution properties of chemically equivalent oxytetracycline hydrochloride powders. | Q46575138 |
| | The physicochemical characteristics of freeze-dried scutellarin-cyclodextrin tetracomponent complexes | Q46749884 |
| | Physical characterization of erythromycin: anhydrate, monohydrate, and dihydrate crystalline solids | Q46894283 |
| | Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process | Q46966998 |
| | Solubility Enhancement of Some Water-Insoluble Drugs in the Presence of Nicotinamide and Related Compounds | Q51714462 |
| | A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability | Q28293773 |
| | Production and characterization of a budesonide nanosuspension for pulmonary administration | Q30825039 |
| | Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir. | Q33986048 |
| | Pharmaceutical co-crystals | Q34489354 |
| | Nanosizing: a formulation approach for poorly-water-soluble compounds | Q35069024 |
| | Nanosuspensions: a promising drug delivery strategy. | Q35826447 |
| | Micellar solubilization of drugs. | Q36241671 |
| | Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. | Q36243834 |
| | Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates | Q36863314 |
| | Supercritical fluid technologies: an innovative approach for manipulating the solid-state of pharmaceuticals. | Q36983209 |
| | Supercritical carbon dioxide processing of active pharmaceutical ingredients for polymorphic control and for complex formation. | Q37002045 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 195727 | |
| P577 | publication date | 2012-07-05 | |
| P1433 | published in | ISRN pharmaceutics | Q27723889 |
| P1476 | title | Drug solubility: importance and enhancement techniques | |
| P478 | volume | 2012 | |